The Hidden Cost of Network Downtime in Biotech
In the biotech industry, where research timelines, clinical trials, and intellectual property are at stake, every second of network downtime carries weight. C-level executives must consider that performance interruptions aren’t just technical nuisances, they’re business threats that can derail productivity, delay breakthroughs, and destroy trust with investors and regulators. While many biotech firms invest heavily […]
How Biotech Firms Can Proactively Prevent Network Downtime
For biotech firms, network downtime is more than a minor inconvenience, it’s a critical failure that can halt experiments, delay clinical trials, and impact regulatory compliance. Smaller biotech firms face an uphill battle in maintaining high-performance IT infrastructure without enterprise-level budgets or in-house IT teams. The good news? Preventing network downtime isn’t out of reach. […]